MedPath

Kefir on Bone Mineral Density and Bone Metabolism in Osteoporotic Patients

Not Applicable
Completed
Conditions
Osteoporosis
Interventions
Other: Kefir
Other: Placebo
Other: CaCO3
Registration Number
NCT02361372
Lead Sponsor
Ministry of Science and Technology, Taiwan
Brief Summary

In a controlled, parallel, double-blind intervention study over 6 months, the investigators investigated the effects of kefir-fermented milk (1,600 mg/kg) supplemented with calcium bicarbonate (CaCO3, 1,500 mg/kg) and bone metabolism in 40 osteoporosis patients, and compared them with CaCO3 alone without kefir supplements. Bone turnover markers were measured in fasting blood samples collected before therapy and at 1, 3, and 6 months. BMD values at the spine, total hip, and hip femoral neck were assessed by dual-energy x-ray absorptiometry (DXA) at baseline and at 6 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  • Clinical diagnosis of osteoporosis patients
Exclusion Criteria
  • Any previous use of parathyroid hormone or sodium fluoride, use of anabolic steroids or growth hormone within 6 months before trial entry or oral or intravenous systemic corticosteroids within 12 months, and any previous use of strontium.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Kefir and CaCO3KefirKefir were administered 1,600 mg kefir-fermented milk per day and an accompanying supplement of 1,500 mg CaCO3 for 6 months
Placebo and CaCO3PlaceboPlacebo and 1,500 mg of CaCO3 daily for 6 months
Placebo and CaCO3CaCO3Placebo and 1,500 mg of CaCO3 daily for 6 months
Primary Outcome Measures
NameTimeMethod
bone mineral density and bone regeneration3 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath